Related Experiment Video
Updated: Jun 27, 2026

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene
H Artee Luchman1, Hallgrimur Benediktsson, Michelle L Villemaire
1Department of Biochemistry and Molecular Biology, and The McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, Canada.
Abstract:
Loss of the PTEN tumor suppressor is a common occurrence in human prostate cancer, particularly in advanced disease. In keeping with its role as a pivotal upstream regulator of the phosphatidylinositol 3-kinase signaling pathway, experimentally-induced deletion of Pten in the murine prostate invariably results in neoplasia. However, and unlike humans where prostate tumorigenesis likely evolves over decades, disease progression in the constitutively Pten deficient mouse prostate is relatively rapid, culminating in invasive cancer within several weeks post-puberty. Given that the prostate undergoes rapid androgen-dependent growth at puberty, and that Pten excisions during this time might be especially tumorigenic, we hypothesized that delaying prostate-specific Pten deletions until immediately after puberty might alter the pace of tumorigenesis. To this end we generated mice with a tamoxifen-inducible Cre recombinase transgene enabling temporal control over prostate-specific gene alterations. This line was then interbred with mice carrying floxed Pten alleles. Despite evidence of increased Akt/mTOR/S6K axis activity at early time points in Pten-deficient epithelial cells, excisions induced in the post-pubertal (6 wk-old) prostate yielded gradual acquisition of a range of lesions. These progressed from pre-malignant changes (nuclear atypia, focal hyperplasia) and low grade prostatic intraepithelial neoplasia (PIN) at 16-20 wks post-tamoxifen exposure, to overtly malignant lesions by approximately 1 yr of age, characterized by high-grade PIN and microinvasive carcinoma. In contrast, when Pten excisions were triggered in the pre-pubertal (2 week-old) prostate, neoplasia evolved over a more abbreviated time-frame, with a spectrum of premalignant lesions, as well as overt PIN and microinvasive carcinoma by 10-12 wks post-tamoxifen exposure. These results indicate that the developmental stage at which Pten deletions are induced dictates the pace of PIN development.
Insights
Loss of the PTEN tumor suppressor gene accelerates prostate cancer development. Inducing PTEN deletion after puberty slows tumor progression, while pre-pubertal deletion leads to rapid cancer evolution.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Loss of the PTEN tumor suppressor is frequent in advanced human prostate cancer.
- PTEN loss in mouse prostate causes rapid neoplasia, unlike human disease progression.
- The timing of PTEN deletion may influence prostate cancer development speed.
Purpose of the Study:
- To investigate if the developmental stage of PTEN deletion impacts prostate cancer progression.
- To determine the effect of post-pubertal versus pre-pubertal PTEN loss on tumorigenesis pace.
Main Methods:
- Generated tamoxifen-inducible Cre-loxP mice for temporal control of prostate-specific Pten deletion.
- Induced Pten deletion in pre-pubertal (2-week-old) and post-pubertal (6-week-old) mice.
- Monitored tumor development and progression over time.
Main Results:
- Post-pubertal Pten deletion resulted in gradual development of pre-malignant lesions and invasive cancer over approximately 1 year.
- Pre-pubertal Pten deletion led to rapid evolution of neoplasia, including high-grade prostatic intraepithelial neoplasia (PIN) and microinvasive carcinoma within 10-12 weeks.
- Early Pten loss showed increased Akt/mTOR/S6K axis activity.
Conclusions:
- The developmental stage of Pten deletion significantly dictates the pace of prostatic intraepithelial neoplasia (PIN) development.
- Targeting PTEN loss timing could be a strategy to modulate prostate cancer progression.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...